Enzotrip A Tablet is a combination pharmaceutical formulation containing Trypsin 48mg, Rutoside 100mg, Bromelain 90mg, and Aceclofenac 100mg, designed to provide effective anti-inflammatory, analgesic, and proteolytic enzyme therapy. Trypsin and Bromelain are proteolytic enzymes that facilitate the breakdown of proteins, promoting the reduction of edema and inflammation by enhancing the absorption of inflammatory exudates. Rutoside, a bioflavonoid, exhibits antioxidant properties and strengthens capillary walls, thereby reducing capillary permeability and fragility, which contributes to decreased swelling and bruising. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), inhibits cyclooxygenase enzymes, leading to reduced synthesis of prostaglandins responsible for pain and inflammation. The synergistic action of these components makes Enzotrip A Tablet effective in managing acute musculoskeletal disorders, post-traumatic inflammation, soft tissue injuries, and postoperative edema. It is indicated for conditions requiring rapid relief from pain and inflammation while promoting tissue healing. This formulation should be used under medical supervision, with caution advised in patients with hypersensitivity to NSAIDs, bleeding disorders, or gastrointestinal ulcers. Enzotrip A Tablet offers a comprehensive approach to inflammation and pain management, enhancing patient recovery and comfort.